Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,440 | 5 | 43.6% |
| Travel and Lodging | $3,038 | 6 | 20.6% |
| Food and Beverage | $2,978 | 122 | 20.2% |
| Unspecified | $2,315 | 8 | 15.7% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $9,963 | 16 | $0 (2021) |
| GlaxoSmithKline, LLC. | $2,669 | 18 | $0 (2024) |
| ABBVIE INC. | $540.10 | 32 | $0 (2024) |
| GENZYME CORPORATION | $478.66 | 22 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $365.04 | 14 | $0 (2024) |
| ALK-Abello, Inc | $168.37 | 8 | $0 (2023) |
| PFIZER INC. | $109.41 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $108.02 | 5 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $89.11 | 4 | $0 (2022) |
| kaleo, Inc. | $81.41 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $701.57 | 34 | ABBVIE INC. ($200.11) |
| 2023 | $3,276 | 50 | GlaxoSmithKline, LLC. ($2,458) |
| 2022 | $602.50 | 28 | ABBVIE INC. ($142.83) |
| 2021 | $10,191 | 29 | Genentech USA, Inc. ($9,963) |
All Payment Transactions
141 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/13/2024 | AERIN MEDICAL INC. | VIVAER STYLUS (Device), RHINAER STYLUS | Food and Beverage | In-kind items and services | $32.33 | General |
| Category: EAR NOSE & THROAT | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Immunology | ||||||
| 09/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/05/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $28.15 | General |
| Category: NEUROSCIENCE | ||||||
| 09/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.48 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/27/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: PAIN | ||||||
| 08/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/01/2024 | kaleo, Inc. | AUVI-Q (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Allergy | ||||||
| 07/30/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: Immunology | ||||||
| 06/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $26.58 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/23/2024 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $18.22 | General |
| Category: Allergy/Immunology | ||||||
| 05/23/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: IMMUNOLOGY | ||||||
| 05/15/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/02/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $26.65 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 04/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: Immunology | ||||||
| 04/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: PAIN | ||||||
| 04/09/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $8.54 | General |
| Category: NEUROSCIENCE | ||||||
| 03/28/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: IMMUNOLOGY | ||||||
| 03/26/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $29.41 | General |
| Category: NEUROSCIENCE | ||||||
| 03/06/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: NEUROSCIENCE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMISED, DOUBLE-BLIND, PARALLEL GROUP PHASE III STUDY TO ASSESS T | GlaxoSmithKline, LLC. | $2,315 | 8 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 301 | 424 | $48,790 | $22,835 |
| 2022 | 8 | 259 | 285 | $52,479 | $16,339 |
| 2021 | 13 | 392 | 403 | $50,432 | $17,223 |
| 2020 | 14 | 584 | 620 | $60,252 | $16,339 |
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 111 | 209 | $18,810 | $11,340 | 60.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 62 | 62 | $7,750 | $3,692 | 47.6% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 21 | 27 | $8,100 | $3,397 | 41.9% |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 2023 | 48 | 58 | $4,575 | $1,603 | 35.0% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2023 | 12 | 17 | $5,100 | $1,403 | 27.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 14 | $1,260 | $529.62 | 42.0% |
| 92557 | Comprehensive hearing and speech recognition test | Office | 2023 | 21 | 23 | $2,070 | $472.53 | 22.8% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 13 | 14 | $1,125 | $398.37 | 35.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 76 | 91 | $8,765 | $5,185 | 59.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 50 | 50 | $6,330 | $3,265 | 51.6% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 18 | 19 | $5,700 | $2,233 | 39.2% |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 2022 | 56 | 66 | $5,175 | $2,213 | 42.8% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 18 | 18 | $20,264 | $1,535 | 7.6% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2022 | 12 | 12 | $3,600 | $1,061 | 29.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 14 | 14 | $1,295 | $495.56 | 38.3% |
| 92557 | Comprehensive hearing and speech recognition test | Office | 2022 | 15 | 15 | $1,350 | $351.79 | 26.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 47 | 48 | $12,432 | $4,018 | 32.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 65 | 68 | $10,835 | $3,621 | 33.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 40 | 40 | $6,584 | $2,477 | 37.6% |
| 31231 | Diagnostic examination of nasal passages using an endoscope | Office | 2021 | 12 | 16 | $4,800 | $1,883 | 39.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $3,754 | $1,389 | 37.0% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 27 | 30 | $3,173 | $1,146 | 36.1% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 22 | 22 | $3,128 | $1,123 | 35.9% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 15 | 15 | $795.00 | $529.95 | 66.7% |
| 80047 | Blood test, basic group of blood chemicals (calcium, ionized) | Office | 2021 | 29 | 29 | $1,566 | $398.17 | 25.4% |
About Jonathan Pender, MS, NP
Jonathan Pender, MS, NP is a Acute Care healthcare provider based in Richmond, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/02/2014. The National Provider Identifier (NPI) number assigned to this provider is 1285052720.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jonathan Pender, MS, NP has received a total of $14,771 in payments from pharmaceutical and medical device companies, with $701.57 received in 2024. These payments were reported across 141 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($6,440).
As a Medicare-enrolled provider, Pender has provided services to 1,536 Medicare beneficiaries, totaling 1,732 services with total Medicare billing of $72,735. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Practice Information
- Specialty Acute Care
- Location Richmond, VA
- Active Since 04/02/2014
- Last Updated 04/02/2014
- Taxonomy Code 363LA2100X
- Entity Type Individual
- NPI Number 1285052720
Products in Payments
- Xofluza (Drug) $9,963
- DUPIXENT (Biological) $843.70
- NUCALA (Biological) $354.39
- QULIPTA (Drug) $234.00
- UBRELVY (Drug) $196.50
- NURTEC ODT (Drug) $193.19
- Odactra (Drug) $127.01
- BOTOX (Biological) $109.60
- AUVI-Q (Drug) $81.41
- XOLAIR (Biological) $56.09
- XOLAIR (Drug) $51.93
- ImmunoCAP (Device) $51.74
- COMIRNATY (Biological) $35.42
- VIVAER STYLUS (Device) $32.33
- Otiprio (Drug) $23.89
- INSPIRE (Device) $21.77
- Grastek (Drug) $17.47
- Ryaltris (Drug) $17.21
- ARES 620 UNICORDER (Device) $14.18
- ORLADEYO (Drug) $12.78
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Acute Care Doctors in Richmond
Rachel Duke, Np, NP
Acute Care — Payments: $636,155
Mica Ferlis, N.p, N.P
Acute Care — Payments: $19,784
Emily Gilbert
Acute Care — Payments: $8,122
Mrs. Linda Hazelgren, Msn,Acnp-Bc,Ccrn, MSN,ACNP-BC,CCRN
Acute Care — Payments: $7,545
Erin Perlmutter, Acnp, ACNP
Acute Care — Payments: $6,937
Christine Robinson, Ag-Acnp, AG-ACNP
Acute Care — Payments: $6,404